Cargill invests in Singapore startup ProfilePrint whose AI tech grades food ingredients quickly and cheaply


ProfilePrint’s platform provides a ‘digital fingerprint’ that shows the quality and profile of food ingredients, such as coffee beans, cocoa and rice, in a matter of seconds. Cargill has completed pilot programmes with ProfilePrint to validate the application of the technology across its portfolio. — SCMP

US food major Cargill has invested in Singapore startup ProfilePrint, which grades food ingredients using artificial intelligence (AI) technology, increasing efficiency and reducing wastage along the supply chain.

ProfilePrint’s patented technology provides a “digital fingerprint” that shows the quality and profile of food ingredients, such as coffee beans, cocoa and rice, in a matter of seconds, according to its CEO and founder Alan Lai.

Save 30% and win Bosch appliances! More Info

Monthly Plan

RM13.90/month
RM9.73 only

Billed as RM9.73 for the 1st month then RM13.90 thereafters.

Annual Plan

RM12.33/month
RM8.63/month

Billed as RM103.60 for the 1st year then RM148 thereafters.

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Nvidia, xAI to join Microsoft, BlackRock to develop AI infrastructure
Amazon's robotaxi unit Zoox recalls 258 vehicles over unexpected braking issue
Foxconn sees server revenue surpassing iPhone revenue in two years, agency report says
Nvidia CEO: Humanoid robot revolution is closer than you think
Big Tech’s data center boom poses new risk to US grid operators
Bumble rolls out ID verification in dating app safety push
A Dutch 'fish doorbell' has turned into an unlikely online hit combining slow TV and ecology
South Korea's SK On wins EV battery deal with Nissan
Analysts say Nintendo Switch 2 might cost over RM2,000, on par with PS5
Chinese pet cloning charges up to US$52,000, raises ethical and health concerns

Others Also Read